Compare · HOLX vs MBAI
HOLX vs MBAI
Side-by-side comparison of Hologic Inc. (HOLX) and MBody AI Ltd. (MBAI): market cap, price performance, sector, and recent activity on the wire.
Summary
- HOLX operates in Health Care, while MBAI operates in Technology - the two are in different parts of the market.
- MBAI carries a market cap of $31.4M.
- MBAI has hit the wire 1 time in the past 4 weeks while HOLX has been quiet.
- HOLX has more recent analyst coverage (25 ratings vs 1 for MBAI).
- Company
- Hologic Inc.
- MBody AI Ltd.
- Price
- -
- -
- Market cap
- -
- $31.4M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Electronics
- EDP Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1990
- 2015
- News (4w)
- 0
- 1
- Recent ratings
- 25
- 1
Hologic Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
MBody AI Ltd.
MBody AI Ltd. (Nasdaq: MBAI) is building the enterprise operating layer for physical AI. Its proprietary MBody AI Orchestrator platform manages supported robots from multiple manufacturers, with a commercial focus on hospitality and gaming. MBody combines software, deployment and service under long-term agreements to help customers put robotic workforces to work.
Latest HOLX
- SEC Form 15-12G filed by Hologic Inc.
- SEC Form EFFECT filed by Hologic Inc.
- SEC Form EFFECT filed by Hologic Inc.
- SEC Form 4 filed by Verstreken Jan
- SEC Form 4 filed by Schnittker Brandon
- SEC Form 4 filed by Schneiders Jennifer M
- SEC Form 4 filed by Oberton Karleen Marie
- SEC Form 4 filed by Mitchell Essex D
- SEC Form 4 filed by Liddy Anne M.
- SEC Form 4 filed by Horvath Mark W.
Latest MBAI
- MBody AI Doubles Deployment at Major Northeast Casino & Entertainment Destination
- MBody AI Grows Resort Business with Caribe Royale Orlando as New Customer
- MBody AI Adds 2 Patents Pending for Its Enterprise AI Workforce Platform
- MBody AI Brings Physical AI Robotics Platform to ThinkEquity and Maxim Investors
- Humanoid Global Highlights MBody AI’s Completion of Nasdaq Transaction and Commercial Robotics Deployment at Mohegan Sun
- SEC Form EFFECT filed by Check-Cap Ltd.
- Northland Capital initiated coverage on MBody AI with a new price target
- MBody AI Presents AI Robot Workforce Platform at Lytham Fall 2026 Conference
- SEC Form F-3 filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.